Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Identify key moments to de-risk in retirement, using timing signals to reduce exposure while preserving income.
27,016 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
The S&P 500 dropped around 1.5% as crude surged on geopolitical worries, reviving inflation fears and tempering expec...
Two clear reasons reasons give cruise line stocks may rebound as travel demand returns and operators strengthen finan...
Lenders are formalizing logging and review practices to protect loan data and title workflows amid rising cybersecuri...
Zcash slid roughly 15% in 48 hours, pushing toward $230 as a classic reversal pattern took hold and market sentiment ...
As regulators settle the status of digital assets and major networks scale, XRP and Solana remain top bets for a long...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
In a historic U.S. mortgage milestone, Coinbase and Better Home & Finance launch the first conforming crypto-backed p...
Bitcoin gains momentum, rising about 6% over the past week and briefly topping $83,000 before pulling back. Traders a...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
Lenders unveil data-driven loan terms tied to connected design, procurement, and field data. The move marks the next ...
U.S. Treasuries sell off as inflation and energy prices push yields toward 5%, signaling cautious sentiment in the de...